Viking stock catapulted Tuesday on "stellar" test results for its weight-loss shot, sending shares of rivals Eli Lilly (LLY) and Novo (NVO) lower. The study examined a every-other-week and monthly doses of Viking Therapeutics' (VKTX) shot, VK2735, for three months as a means of maintaining weight loss on a weekly dose. Patients on the every-other-week schedule maintained up to 97%…
Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8